Juvenescence
A biotech company dedicated to tackling aging and age-related diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD352—528m (Dealroom.co estimates Apr 2020.)
Company register number 11496711
Dublin County Dublin (HQ)
Financials
Estimates*
| GBP | 2018 | 2019 | 2020 |
|---|---|---|---|
| Revenues | <1m | 2.0m | 3.0m |
| % growth | - | 463 % | 45 % |
| EBITDA | - | <1m | <1m |
| % EBITDA margin | - | 10 % | 3 % |
| Profit | <1m | <1m | <1m |
| % profit margin | 7 % | 8 % | 2 % |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
* | $12.3m | Seed | |
| N/A | $50.0m | Series A | |
| N/A | $46.0m | Series B | |
$100m Valuation: $400m 837.1x EV/LTM Revenues | Series B | ||
| N/A | $56.9m | Series C | |
| Total Funding | AUD410m | ||
Related Content
Recent News about Juvenescence
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
